Clinical trial
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in…
NCT00006444 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00006444 |
|---|---|
| Title | The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women |
| Official title | Assessment of Prevalence and Persistence of Human Papillomavirus (HPV) DNA in HIV-Infected Women Who Are Antiretroviral Naive and Have Initiated HAART |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections, Papilloma |
| Enrollment | 160 |
| Start date | Nov 1, 2000 |
| Completion | Aug 1, 2005 |
| First posted | Aug 31, 2001 |
| Last update posted | Nov 20, 2013 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: